Stock Analiz

Zymeworks Inc. (ZYME) stock forecast and price target

Price $26.24 · data as of November 13, 2026

12-month price target

Average target$43.29
Upside / downside+65.0%
Analysts14
ConsensusStrong buy
Low $35.00Average $43.29High $60.00

Gold marker: average target · white marker: today’s price ($26.24)

Analyst ratings

Strong buy 2Buy 12Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$1.51+239.4%$339M
Next fiscal year
ends December 31, 2027
$0.30−80.3%$348M
Next quarter
ends December 31, 2026
$2.19+497.3%$78M
Quarter after
ends December 31, 2026
$-0.20+63.6%$26M

Consensus of the analysts covering Zymeworks, updated daily. In the last 30 days 3 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 65.0% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Zymeworks’s intrinsic value about 91% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Zymeworks stock price target?

The average 12-month target from 14 analysts is $43.29, 65.0% above the current price of $26.24 Targets range from $35.00 to $60.00.

Is Zymeworks a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 12 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Zymeworks expected to earn?

Analysts expect EPS of $1.51 for the fiscal year ending December 31, 2026 and $0.30 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.